All Stories

  1. Strengthening Pathogen and Antimicrobial Resistance Surveillance by Environmental Monitoring in Sub-Saharan Africa: A Stakeholder Survey

    Article • February 2024, MDPI AG

    Mr Vito Baraka

  2. Strengthening Pathogen and Antimicrobial Resistance Surveillance by Environmental Monitoring in Sub-Saharan Africa: A Stakeholder Survey

    Article • February 2024, MDPI AG

    Mr Vito Baraka

  3. Identification of the PfK13 mutations R561H and P441L in the Democratic Republic of Congo

    Article • International Journal of Infectious Diseases, February 2024, Elsevier

    Mr Vito Baraka

  4. Strengthening Pathogen and Antimicrobial Resistance Surveillance by Environmental Monitoring in Sub-Saharan Africa: A Stakeholder Survey

    Article • January 2024, MDPI AG

    Mr Vito Baraka

  5. Unveiling Rare Pathogens and Antibiotic Resistance in Tanzanian Cholera Outbreak Waters

    Article • Microorganisms, October 2023, MDPI AG

    Geofrey Makenga, Mr Vito Baraka

  6. Pf7: an open dataset of Plasmodium falciparum genome variation in 20,000 worldwide samples

    Article • Wellcome Open Research, January 2023, Faculty of 1000, Ltd.

    Mr Vito Baraka

  7. Enrichment of antibiotic resistance genes within bacteriophage populations in saliva samples from individuals undergoing oral antibiotic treatments

    Article • Frontiers in Microbiology, November 2022, Frontiers

    Geofrey Makenga, Mr Vito Baraka

  8. Attributable risk factors for asymptomatic malaria and anaemia and their association with cognitive and psychomotor functions in schoolchildren of north-eastern Tanzania

    Article • PLOS One, May 2022, PLOS

    Geofrey Makenga, Mr Vito Baraka

  9. Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Sub-Saharan Africa: A systematic review and meta-analysis

    Article • PLOS One, March 2022, PLOS

    Mr Vito Baraka

  10. Is it time for Africa to adopt primaquine in the era of malaria control and elimination?

    Article • Tropical Medicine and Health, February 2022, Springer Science + Business Media

    Mr Vito Baraka

  11. Prevalence of asymptomatic malaria, submicroscopic parasitaemia and anaemia in Korogwe District, north-eastern Tanzania

    Article • Malaria Journal, October 2021, Springer Science + Business Media

    Mr Vito Baraka

  12. An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples

    Article • Wellcome Open Research, July 2021, Faculty of 1000, Ltd.

    Mr Vito Baraka

  13. An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples

    Article • Wellcome Open Research, February 2021, Faculty of 1000, Ltd.

    Mr Vito Baraka

  14. Entamoeba gingivalis : epidemiology, genetic diversity and association with oral microbiota signatures in North Eastern Tanzania

    Article • Journal of Oral Microbiology, January 2021, Taylor & Francis

    Mr Vito Baraka

  15. Prevalence of malaria parasitaemia in school-aged children and pregnant women in endemic settings of sub-Saharan Africa: A systematic review and meta-analysis

    Article • Parasite Epidemiology and Control, November 2020, Elsevier

    Geofrey Makenga, Mr Vito Baraka

  16. Assessing the intrinsic and extrinsic drivers and targeting the observed resilience of malaria in northwestern and southern Tanzania: A protocol for a cross-sectional exploratory study

    Article • May 2020, Cold Spring Harbor Laboratory Press

    Mr Vito Baraka

  17. Herpes Simplex virus type 2 seroprevalence and risk factors among adolescents and youth with HIV-1 in Northern, Tanzania

    Article • The Journal of Infection in Developing Countries, April 2020, Journal of Infection in Developing Countries

    Mr Vito Baraka

  18. Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania

    Article • Malaria Journal, April 2020, Springer Science + Business Media

    Mr Vito Baraka

  19. Effectiveness and safety of intermittent preventive treatment for malaria using either dihydroartemisinin-piperaquine or artesunate-amodiaquine in reducing malaria related morbidities and improving cognitive ability in school-aged children in Tanzania:...

    Article • Contemporary Clinical Trials Communications, March 2020, Elsevier

    Geofrey Makenga, Mr Vito Baraka

  20. Usefulness of day 7 lumefantrine plasma concentration as a predictor of malaria treatment outcome in under-fives children treated with artemether-lumefantrine in Tanzania

    Article • Malaria Journal, February 2020, Springer Science + Business Media

    Mr Vito Baraka

  21. An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples

    Article • November 2019, Cold Spring Harbor Laboratory Press

    Mr Vito Baraka

  22. Emerging implications of policies on malaria treatment: genetic changes in the Pfmdr-1 gene affecting susceptibility to artemether–lumefantrine and artesunate–amodiaquine in Africa

    Article • BMJ Global Health, October 2018, BMJ

    Mr Vito Baraka

  23. Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda

    Article • PLOS One, February 2018, PLOS

    Mr Vito Baraka

  24. Habitat productivity and pyrethroid susceptibility status of Aedes aegypti mosquitoes in Dar es Salaam, Tanzania

    Article • Infectious Diseases of Poverty, June 2017, Springer Science + Business Media

    Mr Vito Baraka

  25. Different origin and dispersal of sulphadoxine-resistant Plasmodium falciparum haplotypes between Eastern Africa and Democratic Republic of Congo

    Article • International Journal of Antimicrobial Agents, February 2017, Elsevier

    Mr Vito Baraka

  26. Performance of health laboratories in provision of HIV diagnostic and supportive services in selected districts of Tanzania

    Article • BMC Health Services Research, January 2017, Springer Science + Business Media

    Mr Vito Baraka

  27. Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of first-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, random...

    Article • The Lancet Global Health, January 2017, Elsevier

    Mr Vito Baraka

  28. The Threat of Zika Virus in Sub-Saharan Africa – The Need to Remain Vigilant

    Article • Frontiers in Public Health, May 2016, Frontiers

    Mr Vito Baraka, Prof. ELININGAYA KWEKA

  29. Genomic epidemiology of artemisinin resistant malaria

    Article • eLife, March 2016, eLife

    Mr Vito Baraka

  30. Current Epidemiological Assessment of Bancroftian Filariasis in Tanga Region, Northeastern Tanzania

    Article • Journal of Tropical Medicine, January 2016, Wiley

    Mr Vito Baraka

  31. Risks of Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficient Infants Exposed to Chlorproguanil-Dapsone, Mefloquine and Sulfadoxine-Pyrimethamine as Part of Intermittent Presumptive Treatment of Malaria in Infants

    Article • PLOS One, November 2015, PLOS

    Mr Vito Baraka

  32. High-level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of septuple haplotype in Tanzania

    Article • Malaria Journal, November 2015, Springer Science + Business Media

    Mr Vito Baraka

  33. Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania

    Article • Malaria Journal, July 2015, Springer Science + Business Media

    Mr Vito Baraka

  34. The readiness of the national health laboratory system in supporting care and treatment of HIV/AIDS in Tanzania

    Article • BMC Health Services Research, June 2015, Springer Science + Business Media

    Mr Vito Baraka

  35. In VivoSelection of Plasmodium falciparumPfcrtandPfmdr1Variants by Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine in Burkina Faso

    Article • Antimicrobial Agents and Chemotherapy, November 2014, ASM Journals

    Mr Vito Baraka

  36. Plasmodium falciparum erythrocyte membrane protein 1 domain cassettes 8 and 13 are associated with severe malaria in children

    Article • Proceedings of the National Academy of Sciences, May 2012, Proceedings of the National Academy of Sciences

    Mr Vito Baraka